For patients with multiple sclerosis (MS), magnetic resonance imaging (MRI) and clinical assessments do not appear to offer long-term prognostic value.
Bruce Cree, M.D., Ph.D., from the University of California San Francisco Multiple Sclerosis Center, and colleagues conducted a prospective study involving 517 actively managed MS patients. They examined whether clinical and MRI data had long-term prognostic value.
"The data call into question the utility of annual MRI assessments as a treat-to-target approach for MS care," the authors write.
Comment